With 80% of clinical trials failing to finish on time (and 20% of those delayed 6+ months) every day of…
With 76% of Phase I-IV trials now requiring amendments--up from 57% in 2015--protocol changes have become one of the most…
The FDA's Project Optimus has reformed dose optimization and selection requirements. Sponsors who understand the new framework are seeing more…
See how Climb simplifies early-stage in vivo research by unifying experiment design, animal scheduling, and data capture in one platform.…
Pri-Med offers solutions that bridge the gap between your pharma clients’ teams and hard-to-see clinicians. As the healthcare landscape evolves,…
Leverage the largest metabolite library to advance your study objectives. Strategic Research Partners We partner with the world’s largest research…
Sign in to your account